2m 2m 2m 2m 2m 2m 2m
RELMADA THERAPEU (RLMD)
NASDAQ
$6.82+$0.05 (+0.80%)
Price as of Jun 23, 2026 6:59 PM EDT- $722.7MMarket Cap
- 1,043.77%1-Year Change
- BiotechnologyIndustry
RELMADA THERAPEU (RLMD)
$6.82+$0.05 (+0.80%)
RLMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.77 | ||
Change | -$0.12 (-1.74%) | ||
Open | $6.74 | ||
High | $7.02 | ||
Low | $6.66 | ||
Previous Close | $6.89 | ||
Volume | 1,674,457 | ||
30-Day Average Volume | 1,430,768 | ||
1-Week Change | 3.36% | ||
1-Month Change | -3.84% | ||
1-Year Change | 1,043.77% | ||
3-Year Change | 174.09% | ||
5-Year Change | -78.95% | ||
Fundamentals | |||
Shares Outstanding | 104.9M | ||
Total Assets | $235.4M | ||
Market Cap | $722.7M | ||
Enterprise Value | $712.9M | ||
Period: QTR TTM FY | |||
Revenue | -$549,964.00 | ||
Net Income | -$19.1M | ||
Free Cash Flow | -$15.1M | ||
EBIT | -$19.1M | ||
EBITDA | -$19.1M | ||
Net Working Capital | $222.5M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | -37 | ||
Enterprise Value/Revenue | -1,296 | ||
P/B | 3 | ||
P/E | -31 | ||
PEG | -1 | ||
Price/Free Cash Flow | -48 | ||
Price/Operating Cash Flow | -48 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 09/30/2019 | ||
Earnings & Revenue